Lise Larsen

1.1k total citations
15 papers, 880 citations indexed

About

Lise Larsen is a scholar working on Cancer Research, Molecular Biology and Immunology and Allergy. According to data from OpenAlex, Lise Larsen has authored 15 papers receiving a total of 880 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 7 papers in Molecular Biology and 5 papers in Immunology and Allergy. Recurrent topics in Lise Larsen's work include Protease and Inhibitor Mechanisms (11 papers), Liver physiology and pathology (5 papers) and Cell Adhesion Molecules Research (5 papers). Lise Larsen is often cited by papers focused on Protease and Inhibitor Mechanisms (11 papers), Liver physiology and pathology (5 papers) and Cell Adhesion Molecules Research (5 papers). Lise Larsen collaborates with scholars based in Denmark, United States and United Kingdom. Lise Larsen's co-authors include M.A. Karsdal, Diana Julie Leeming, Sanne Skovgård Veidal, Natasha Barascuk, Qinlong Zheng, Martin R. Larsen, Jannie Marie Bülow Sand, Dorthe Vang Larsen, Lars Melholt Rasmussen and Arkadiusz Nawrocki and has published in prestigious journals such as PLoS ONE, Journal of Molecular and Cellular Cardiology and Clinical Biochemistry.

In The Last Decade

Lise Larsen

15 papers receiving 872 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lise Larsen Denmark	14	215	200	158	153	135	15	880
N.S. Gudmann Denmark	18	295 1.4×	256 1.3×	217 1.4×	118 0.8×	118 0.9×	37	1.1k
Shu Sun Denmark	17	324 1.5×	170 0.8×	108 0.7×	171 1.1×	208 1.5×	45	1.2k
Borut Klopcic Australia	10	233 1.1×	264 1.3×	264 1.7×	65 0.4×	77 0.6×	13	747
Keiji Nakasho Japan	18	319 1.5×	201 1.0×	193 1.2×	107 0.7×	165 1.2×	82	1.2k
Shiu-Feng Huang Taiwan	20	241 1.1×	187 0.9×	147 0.9×	120 0.8×	292 2.2×	42	1.1k
Makoto Toi Japan	17	340 1.6×	111 0.6×	65 0.4×	158 1.0×	227 1.7×	65	800
Hideaki Takahashi Japan	20	305 1.4×	368 1.8×	154 1.0×	117 0.8×	184 1.4×	93	1.3k
Hirokazu Kawai Japan	21	199 0.9×	300 1.5×	356 2.3×	131 0.9×	105 0.8×	63	987
Noriko Sakaida Japan	17	470 2.2×	255 1.3×	229 1.4×	172 1.1×	256 1.9×	45	1.2k
Lasse Langholm Denmark	8	146 0.7×	118 0.6×	84 0.5×	62 0.4×	120 0.9×	16	571

Countries citing papers authored by Lise Larsen

Since Specialization

Citations

This map shows the geographic impact of Lise Larsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lise Larsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lise Larsen more than expected).

Fields of papers citing papers by Lise Larsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lise Larsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lise Larsen. The network helps show where Lise Larsen may publish in the future.

Co-authorship network of co-authors of Lise Larsen

This figure shows the co-authorship network connecting the top 25 collaborators of Lise Larsen. A scholar is included among the top collaborators of Lise Larsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lise Larsen. Lise Larsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Fang, Wenqian, Aina He, Meixiang Xiang, et al.. (2018). Cathepsin K-deficiency impairs mouse cardiac function after myocardial infarction. Journal of Molecular and Cellular Cardiology. 127. 44–56. 24 indexed citations

Willumsen, Nicholas, et al.. (2016). Type VIII collagen is elevated in diseases associated with angiogenesis and vascular remodeling. Clinical Biochemistry. 49(12). 903–908. 41 indexed citations

Kristensen, Jacob Hull, Lise Larsen, B. Dasgupta, et al.. (2015). Levels of circulating MMP-7 degraded elastin are elevated in pulmonary disorders. Clinical Biochemistry. 48(16-17). 1083–1088. 27 indexed citations

Genovese, Federica, Natasha Barascuk, Lise Larsen, et al.. (2013). Biglycan fragmentation in pathologies associated with extracellular matrix remodeling by matrix metalloproteinases. PubMed. 6(1). 9–9. 51 indexed citations

Sand, Jannie Marie Bülow, Lise Larsen, Cory M. Hogaboam, et al.. (2013). MMP Mediated Degradation of Type IV Collagen Alpha 1 and Alpha 3 Chains Reflects Basement Membrane Remodeling in Experimental and Clinical Fibrosis – Validation of Two Novel Biomarker Assays. PLoS ONE. 8(12). e84934–e84934. 154 indexed citations

Barascuk, Natasha, Federica Genovese, Lise Larsen, et al.. (2013). A MMP derived versican neo-epitope is elevated in plasma from patients with atherosclerotic heart disease.. PubMed. 6(3). 174–84. 26 indexed citations

Nielsen, Mette Juul, Anders Nedergaard, Shu Sun, et al.. (2013). The neo-epitope specific PRO-C3 ELISA measures true formation of type III collagen associated with liver and muscle parameters.. PubMed. 5(3). 303–15. 184 indexed citations

Skjøt‐Arkil, Helene, Natasha Barascuk, Lise Larsen, et al.. (2011). Tumor Necrosis Factor-Alpha and Receptor Activator of Nuclear Factor-κB Ligand Augment Human Macrophage Foam-Cell Destruction of Extracellular Matrix Through Protease-Mediated Processes. Assay and Drug Development Technologies. 10(1). 69–77. 5 indexed citations

Vassiliadis, Efstathios, Dorthe Vang Larsen, Sanne Skovgård Veidal, et al.. (2011). Measurement of CO3-610, a Potential Liver Biomarker Derived from Matrix Metalloproteinase-9 Degradation of Collagen Type III, in a Rat Model of Reversible Carbon-Tetrachloride-Induced Fibrosis. Biomarker Insights. 6. BMI.S6347–BMI.S6347. 39 indexed citations

10.

Barascuk, Natasha, Efstathios Vassiliadis, Lise Larsen, et al.. (2011). Development and validation of an enzyme-linked immunosorbent assay for the quantification of a specific MMP-9 mediated degradation fragment of type III collagen—A novel biomarker of atherosclerotic plaque remodeling. Clinical Biochemistry. 44(10-11). 900–906. 25 indexed citations

11.

Vassiliadis, Efstathios, Sanne Skovgård Veidal, Natasha Barascuk, et al.. (2011). Measurement of matrix metalloproteinase 9-mediated Collagen type III degradation fragment as a marker of skin fibrosis. BMC Dermatology. 11(1). 6–6. 33 indexed citations

12.

Barascuk, Natasha, Efstathios Vassiliadis, Yong Wang, et al.. (2011). Levels of Circulating MMCN-151, a Degradation Product of Mimecan, Reflect Pathological Extracellular Matrix Remodeling in Apolipoprotein E Knockout Mice. Biomarker Insights. 6. BMI.S7777–BMI.S7777. 15 indexed citations

13.

Barascuk, Natasha, Sanne Skovgård Veidal, Lise Larsen, et al.. (2010). A novel assay for extracellular matrix remodeling associated with liver fibrosis: An enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope of type III collagen. Clinical Biochemistry. 43(10-11). 899–904. 195 indexed citations

14.

Barascuk, Natasha, Helene Skjøt‐Arkil, Thomas C. Register, et al.. (2010). Human macrophage foam cells degrade atherosclerotic plaques through cathepsin K mediated processes. BMC Cardiovascular Disorders. 10(1). 19–19. 38 indexed citations

15.

Dowell, Barry L., Kent D. Stewart, Vibeke Jensen, et al.. (2005). Establishment and Characterization of 7 New Monoclonal Antibodies to Tissue Inhibitor of Metalloproteinases-1. Tumor Biology. 26(2). 71–80. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact